CBD gummies are a type of candy that contains CBD oil. CBD is a compound found in cannabis plants that have been shown to provide various health benefits. Unlike THC, the other main compound in cannabis, CBD does not produce any psychoactive effects. It implies that it does not make you feel high or intoxicated. CBD gummies are usually made from CBD isolate, which means they contain no other cannabinoids from the cannabis plant. If you want to give CBD gummies a try, purchase them from cbdMD at CBD.co.
How Do CBD Gummies Work?
CBD gummies are a popular type of CBD edible used for various purposes.CBD gummies typically contain a certain amount of CBD isolate or extract and are flavored with fruit juices or other sweeteners. When you eat a CBD gummy, the CBD is absorbed into your bloodstream through digestion. It implies that it takes a little longer for the effects of CBD to kick in when you eat a gummy than other methods like smoking or vaporizing. However, the effects of CBD gummies tend to last longer than other methods. It is because when you digest CBD, it is broken down by liver enzymes and metabolized more slowly than when inhaled. As a result, the effects of CBD can last anywhere from four to six hours when taken in gummy form.
Why Should You Replace Regular Candles With CBD Gummies?
Regular candies, on the other hand, do not contain any CBD. While you can enjoy both regular candies and CBD gummies for their sweet taste, there are some critical differences between these two types of confections. Here is the list of reasons why you should replace regular candies with CBD Gummies:
● CBD gummies are a healthier alternative to candy
For many people, candy is a guilt-inducing treat. It’s full of sugar and empty calories, and it’s too easy to overindulge. CBD gummies offer a healthier alternative. Made with natural CBD oil ingredients, they provide the same sweet taste without the sugar crash. And because CBD is known for its calming effects, it can also help reduce stress and anxiety. Gummies are a delicious option for those seeking a sweeter way to consume CBD. And because they’re available in various colors and flavors, there’s sure to be one perfect for you.
● CBD gummies typically contain less sugar than regular candies
CBD gummies are a candy containing cannabidiol (CBD), a hemp-derived compound that has been shown to offer various potential health benefits. Unlike THC, the other primary compound found in cannabis, CBD is non-intoxicating, meaning it won’t make you feel “high.” It makes CBD an exciting option for people looking for the potential benefits of cannabis without the psychoactive effects. CBD gummies are typically made with CBD isolate, which contains no other compounds from the cannabis plant. It implies that they typically contain minimal THC (less than 0.3%), so they shouldn’t produce any psychoactive effects. In addition to being non-intoxicating, CBD gummies usually contain less sugar than regular candies. It makes these gummies an excellent choice for people watching their sugar intake or simply looking for a healthier alternative to traditional sweets. On the other hand, regular candy is made with sugar and other ingredients that can aggravate existing health conditions. Thus, you should try replacing your regular candies with CBD gummies.
● Artificial Flavors and Colors vs. Natural Ingredients
CBD gummies are a tasty method to consume CBD for those with a sweet tooth. Unlike regular candies that are made with artificial flavors and colors, CBD gummies are usually made with natural ingredients. It makes them healthier and gives them a more pleasant flavor. In addition, CBD gummies provide the same benefits as other CBD products, such as reducing anxiety and relieving pain. Consequently, they are a popular choice for those looking for an easy and enjoyable way to consume CBD.
● CBD gummies help you stay focused and productive
When it comes to staying focused and productive, there are a variety of strategies that people can use. For some, a cup of coffee in the morning is all it takes to get going. Other people take regular breaks throughout the day to stay on task. However, for many people, the key to staying focused and productive is CBD gummies. Unlike regular candies, CBD gummies are infused with cannabidiol, a compound found in cannabis plants. CBD does not produce the psychoactive effects associated with marijuana. In addition, CBD gummies provide a healthy alternative to sugary snacks that can lead to a mid-day crash. So if you’re looking for a way to boost your productivity, CBD gummies may be worth considering.
● CBD gummies can boost your immune system
CBD gummies are a type of candy that contains CBD oil. CBD is among the 100+ cannabinoids in the hemp plant. Some people believe that CBD can boost the immune system. There is no such scientific evidence to support this claim; it is still possible that CBD could help to boost the immune system by reducing inflammation. Inflammation is a crucial driver of many diseases, and if CBD can reduce inflammation, it stands to reason that it could also help to prevent or treat specific diseases. In addition, CBD is well-known to have anti-anxiety and anti-stress effects, which could help boost the immune system by reducing stress levels. While more scientific evidence is needed to confirm the potential health benefits of CBD gummies, they are certainly a delicious and potentially health-boosting treat.
● CBD gummies can improve your sleep quality
If you’re looking for a natural way to improve your sleep quality, CBD gummies might be worth considering. CBD is a non-psychoactive substance extracted from the Cannabis Sativa plant and offers numerous potential health benefits. Some research suggests that CBD may help relieve anxiety and pain, which can interfere with sleep. In addition, people believe that CBD has anti-inflammatory and antioxidant properties, which may also improve sleep quality.
While regular candies do not contain CBD, they may still contain sugar and caffeine, which can disrupt sleep. In contrast, CBD gummies are non-addictive and have no known side effects. Consequently, they are an excellent choice for those who want to improve their sleep quality.
WHO, Edo Intensify Response to Combat Monkeypox
By Adedapo Adesanya
The World Health Organisation (WHO) and the Edo State government have intensified a coordinated response to contain the spread of the Monkeypox disease.
So far, Nigeria has reported 357 suspected cases with 133 confirmed monkeypox cases from 25 states – Lagos, Adamawa, Delta, Rivers, Edo, Bayelsa, Nasarawa Plateau FCT, Ondo, Anambra Cross River, Kwara, Borno, Taraba, Oyo, Imo, Kano, Katsina, Gombe, Niger Ogun, Kogi, Bauchi, Akwa Ibom and Abia.
Meanwhile, eight persons have so far tested positive for monkeypox in Edo state, and all the people diagnosed with the disease have recovered.
The Director, Public Health, Edo State Ministry of Health, Dr Ojeifo Stephenson, said it has become imperative to warn the residents of the state about the health risks that the virus poses and reiterate the need to be cautious and adhere to preventive measures.
He said the state Ministry of Health with support from the World Health Organization (WHO) and partners, has ramped up surveillance, diagnostics and other activities to curb the spread of infectious diseases.
“We have stepped up surveillance including prompt investigation of suspected cases, facilitating documentation of contacts, contact tracing and monitoring, as well as developed and disseminated public health advisory to raise awareness about the disease among residents of the state,” he said.
Additionally, Dr Benson Okwara, who works at UBTH, said WHO has been an invaluable partner in the response to monkeypox diagnosis and treatment in the facility.
Dr Okwara has five years of experience in managing patients with monkeypox.
He lamented that the disease spreads within the communities because of the poor health-seeking behaviour and late presentation of the case to the hospital.
“However, with WHO’s coordination, there is an early response following notification of suspected/confirmed cases with detailed case investigations using the monkeypox case investigation form (CIF) to collect data on patient contacts.
“There is a need for continuous risk messaging to educate people about infectious diseases and the importance of seeking medical care early and at appropriate health facilities to prevent the spread of diseases,” he said.
Across Nigeria, the Nigeria Centre for Disease Control (NCDC), supported by WHO, has activated Monkeypox Emergency Operations Centre to strengthen in-country preparedness and contribute to the global response to the outbreak.
Furthermore, WHO is supporting the coordination of technical assistance and operational support of partners, including the national One-health risk surveillance and information sharing (NOHRSIS) group, to facilitate timely information exchange on all prioritized zoonotic diseases.
Monkeypox is a zoonotic disease endemic in Nigeria and some parts of Africa.
However, there has been sporadic spread to other countries as more than 16,000 cases of monkeypox have been reported across more than 70 countries so far this year, and the number of confirmed infections rose 77 per cent from late June through early July.
The virus is being transmitted from animals to humans.
Recently, WHO activated its highest alert level for the growing monkeypox outbreak, declaring the virus a public health emergency of international concern.
WHO to Help Nigeria Achieve NHIA Act 2022 Objectives
By Adedapo Adesanya
The World Health Organization (WHO) has expressed its desire to support Nigeria in operationalising the National Health Insurance Authority (NHIA) Act 2022 signed by President Muhammadu Buhari in May 2022.
WHO’s Country Representative (WR), Dr Walter Kazadi Mulombo, made this pledge during a high-level meeting with the Secretary to the Government of the Federation (SGF), Mr Boss Mustapha, the Director General, National Health Insurance Authority (NHIA), Professor Mohammed Sambo, and a team of WHO Health Financing Mission delegates from the WHO Geneva, Africa Regional Office, and Nigeria.
The first ever high-level WHO Health Financing Mission to Nigeria, led by Dr Joseph Kutzin, was scheduled to provide sustainable health financing support to the country towards Universal Health Coverage (UHC) and health security while undertaking targeted advocacy to accelerate operationalization of the NHIA Act including the Vulnerable Group Fund (VGF).
This is in line with WHO’s goal of ensuring that all individuals and communities receive the quality health services they need without suffering financial hardship.
Dr Mulombo said President Buhari’s signing of the NHIA Bill into law will make health insurance mandatory for all legal residents in Nigeria and expands coverage to over 83 million poor and vulnerable people.
He expressed the optimism that government will prioritize immediate appropriation of the Special Intervention Fund in the Act to establish the Vulnerable Group Fund.
“Indeed, the task of ensuring that all citizens have access to the quality healthcare they need without falling into poverty is a deliberate political decision to achieve the cardinal objectives of population coverage, service coverage, and financial protection. I have no doubts that in a large federal nation like Nigeria, this milestone of appropriating the Special Intervention Fund will be achieved in the 2023 fiscal year”, he said.
In his remarks, Mr Mustapha appreciated WHO as the foremost development partner to Nigeria on health and lauded WHO’s invaluable guidance, particularly on the COVID-19 pandemic.
“WHO has demonstrated that it is an organization that cares for and caters for the health needs of the people. On the NHIA, let me commend the DG for his tenacity and determination to have this Act come to fruition. I want to thank WHO and other partners who supported in the drafting of the Bill. This modest attempt has provided basic health insurance coverage to the vulnerable, and making it mandatory will go a long way in assisting our people to manage their income and remain at work in terms of the depressed economy we are witnessing”.
The SGF further expressed the government’s commitment to appropriate the Special Intervention Fund (SIF) in the 2023 national budget for the establishment of the Vulnerable Group Fund (VGF).
“No family in Nigeria has economically survived catering for any of their own suffering from cancer. The health of our people is therefore topmost on our priorities despite competing demands”, he stated.
Monkeypox: Russians Are Back With Cheap Health Publicity
By Kestér Kenn Klomegâh
With rising cases of the monkeypox virus, Russians are back seeking again cheap health publicity in Africa. Just as Foreign Minister Sergey Lavrov completed his four African-nation tours, Russia plans to send monkeypox test kits to Egypt, Uganda, Ethiopia and Congo.
Russian consumer health watchdog Rospotrebnadzor said in a media statement that Russian test systems to diagnose monkeypox would be provided to Egypt, Uganda, Ethiopia, and the Republic of Congo at the end of July.
“Rospotrebnadzor is continuing to extend support to partner countries’ efforts to counter the spread of monkeypox. Test systems produced by Rospotrebnadzor’s Vector Research Center will be handed over to Egypt, Uganda, Ethiopia, and the Republic of Congo at the end of July,” the press service said.
“Furthermore, Rospotrebnadzor specialists are arranging special workshops for colleagues from partner countries that deal with laboratory methods to diagnose monkeypox,” it said.
Rospotrebnadzor said earlier that the Vector Research Center had produced monkeypox test kits, and such testing is currently available in all Russian regions.
Monkeypox is a rare infectious disease, most common in remote parts of Central and West Africa. Its symptoms include nausea, fever, rash, itch and muscle pain.
On July 12, Rospotrebnadzor announced the first national case of monkeypox: the patient had returned from Portugal. His symptoms were mild and did not endanger the patient’s life. Rospotrebnadzor said that all his contacts had been promptly identified and were under medical monitoring. The threat of spread has been contained.
Faced with a surge in monkeypox cases, the World Health Organization (WHO) has already declared the outbreak of monkeypox as a global health emergency — the highest alarm it sounded. Monkeypox has affected over 15,800 people in 72 countries, according to a tally by the US Centers for Disease Control and Prevention (CDC) published on July 20.
WHO, however, warned against discrimination. “A failure to act will have grave consequences for global health,” Lawrence Gostin, the director of the WHO Collaborating Center on National and Global Health Law, said on Twitter.
Some experts have asked why Russians have not chosen African countries such as Nigeria, or regions such as Central and West Africa where the virus is currently spreading most. But have listed as priority countries that Sergey Lavrov visited on 24-27 July: Egypt, Ethiopia, Uganda and the Republic of the Congo.
Latest News on Business Post
- International Youth Day 2022 and Nigerian Youth Ordeals August 12, 2022
- A Thoughtful Approach to Wealth Management August 12, 2022
- Firm Launches Yellow Pay to Facilitate Easy Intercontinental Transactions August 12, 2022
- Verification of Bank of Agriculture Pensioners Begins August 12, 2022
- Twitter Introduces Location Spotlight, Others to Benefit Professionals, Businesses August 12, 2022
- CitiTrust Lifts Over-the-Counter Bourse by 0.05% August 12, 2022
- Value of Naira Falls at P2P, I&E, Parallel Market as Forex Scarcity Worsens August 12, 2022
- Crude Oil Jumps 2% as IEA Forecast 2022 Demand Growth August 12, 2022
- Treasury Bills Rates Rise Across Tenors at Primary Market August 12, 2022
- Equity Exchange Loses N33bn Amid Low Turnover August 12, 2022